DK1407780T3 - Farmaceutisk stabile hæmostatiske præparater - Google Patents

Farmaceutisk stabile hæmostatiske præparater

Info

Publication number
DK1407780T3
DK1407780T3 DK02745897.5T DK02745897T DK1407780T3 DK 1407780 T3 DK1407780 T3 DK 1407780T3 DK 02745897 T DK02745897 T DK 02745897T DK 1407780 T3 DK1407780 T3 DK 1407780T3
Authority
DK
Denmark
Prior art keywords
stable hemostatic
pharmaceutical stable
hemostatic preparations
preparations
pharmaceutical
Prior art date
Application number
DK02745897.5T
Other languages
English (en)
Inventor
Tatsuya Araki
Kazuhiko Tomokiyo
Yasushi Nakatomi
Kaori Teshima
Tomohiro Nakagaki
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of DK1407780T3 publication Critical patent/DK1407780T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK02745897.5T 2001-07-10 2002-07-10 Farmaceutisk stabile hæmostatiske præparater DK1407780T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001209921 2001-07-10
PCT/JP2002/006982 WO2003006054A1 (fr) 2001-07-10 2002-07-10 Compositions hemostatiques pharmaceutiquement stables

Publications (1)

Publication Number Publication Date
DK1407780T3 true DK1407780T3 (da) 2013-05-13

Family

ID=19045493

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02745897.5T DK1407780T3 (da) 2001-07-10 2002-07-10 Farmaceutisk stabile hæmostatiske præparater

Country Status (10)

Country Link
US (1) US7329724B2 (da)
EP (1) EP1407780B1 (da)
JP (1) JP4813017B2 (da)
KR (1) KR101067400B1 (da)
CN (1) CN1254273C (da)
AU (1) AU2008203028B2 (da)
CA (1) CA2452395C (da)
DK (1) DK1407780T3 (da)
ES (1) ES2407134T3 (da)
WO (1) WO2003006054A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0402315A3 (en) 2001-12-21 2009-03-30 Novo Nordisk Healthcare Ag Liquid composition of factor vii polypeptides
CN1671410B (zh) 2002-06-21 2010-05-12 诺和诺德医疗保健公司 因子ⅶ多肽的稳定化固体组合物
ES2335994T3 (es) * 2003-07-01 2010-04-07 Novo Nordisk Health Care Ag Composicion farmaceutica liquida, acuosa de polipeptidos factor vii.
JP4613133B2 (ja) * 2003-10-09 2011-01-12 一般財団法人化学及血清療法研究所 アンチトロンビンｉｉｉ含有止血用組成物
GB0324044D0 (en) 2003-10-14 2003-11-19 Astrazeneca Ab Protein
EP3378470A1 (en) * 2003-12-19 2018-09-26 Novo Nordisk Health Care AG Stabilised compositions of factor vii polypeptides
EP1874928A1 (en) 2005-04-13 2008-01-09 AstraZeneca AB A host cell comprising a vector for production of proteins requiring gamma-carboxylation
EP1728798A1 (en) 2005-06-01 2006-12-06 ZLB Behring GmbH Coagulation factor X polypeptides with modified activation properties
EP1820508A1 (en) 2006-02-21 2007-08-22 CSL Behring GmbH Coagulation factor X polypeptides with modified activation properties
EP1958618A1 (de) * 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
US8206967B2 (en) 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin
JP6659591B2 (ja) 2014-06-09 2020-03-04 テルモ ビーシーティー、インコーポレーテッド 凍結乾燥
CN111295094A (zh) 2017-10-09 2020-06-16 泰尔茂比司特生物技术有限公司 冻干容器及使用冻干容器的方法
JP2022525742A (ja) 2019-03-14 2022-05-19 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥用ローディングトレイ組立体及びシステム

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
DE19531637A1 (de) 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
JP4676585B2 (ja) * 1999-12-24 2011-04-27 一般財団法人化学及血清療法研究所 血液凝固異常に基づく疾患の治療・予防用医薬組成物

Also Published As

Publication number Publication date
US20040147439A1 (en) 2004-07-29
AU2008203028B2 (en) 2011-08-11
JP4813017B2 (ja) 2011-11-09
CN1254273C (zh) 2006-05-03
CN1525867A (zh) 2004-09-01
US7329724B2 (en) 2008-02-12
JPWO2003006054A1 (ja) 2004-10-28
ES2407134T3 (es) 2013-06-11
AU2008203028A1 (en) 2008-07-31
CA2452395A1 (en) 2003-01-23
EP1407780A1 (en) 2004-04-14
KR20040013133A (ko) 2004-02-11
EP1407780A4 (en) 2010-12-15
WO2003006054A1 (fr) 2003-01-23
EP1407780B1 (en) 2013-05-01
KR101067400B1 (ko) 2011-09-27
CA2452395C (en) 2012-04-10

Similar Documents

Publication Publication Date Title
NO20033556D0 (no) Farmasöytiske preparater
NO20033384D0 (no) Farmasöytisk formulering
NO20071303L (no) Farmasoytiske preparater
NO20033785D0 (no) Farmasöytisk formulering
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
ITTO20010008A0 (it) Formulazione farmaceutica
FI20011478A0 (fi) Farmaseuttinen koostumus
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
DK1524266T3 (da) Farmaceutisk sammensætning
DK1395242T3 (da) Flydende farmaceutisk sammensætning
NO20035627D0 (no) Farmasöytisk formulering
NO20035315D0 (no) Farmasöytiske kombinasjoner
DK1407780T3 (da) Farmaceutisk stabile hæmostatiske præparater
DE50209245D1 (de) Neuroprotektives medikament
FI20022128A0 (fi) Farmaseuttinen koostumus
NO20042502L (no) Farmasoytisk formulering omfattende bicalutamid
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
DE10291905D2 (de) Pharmazeutische Zusammensetzung
NO20015534D0 (no) Farmasöytisk blandeapparat
DE10107261B4 (de) Pharmazeutische Zusammensetzung
NO20041236L (no) Farmasoytisk formulering
EE200200689A (et) Ravimkoostised
DE60204435D1 (de) Spritze
DE60206034D1 (de) Spritze
SE0101326D0 (sv) Pharmaceutical formulation